文献引用
-
1) Lactylated SPTAN1 Accelerates Hepatocellular Carcinoma Progression by Promoting NOTCH1/HES1 Activation and Immunosuppression.
-
2) Dysregulation of CircZNF79(5) Modulates YBX1 Stability and Selective Autophagy to Drive Hepatocellular Carcinoma Progression.
-
3) BRD4-targeted photodegradation nanoplatform for light activatable melanoma therapy.
-
4) Engineered cell membrane vesicles loaded with lysosomophilic drug for acute myeloid leukemia therapy via organ-cell-organelle cascade-targeting.
-
5) SOX4 facilitates brown fat development and maintenance through EBF2-mediated thermogenic gene program in mice.
-
6) USP25 directly interacts with and deubiquitinates PPARα to increase PPARα stability in hepatocytes and attenuate high-fat diet-induced MASLD in mice.
-
7) DUBA sustains the stability of NOD2 and RIPK2 to enhance innate immune responses.
-
8) Deacetylation of ANXA2 by SIRT2 desensitizes hepatocellular carcinoma cells to donafenib via promoting protective autophagy.
-
9) Phytosphingosine contributes gut microbiota metabolism to alleviate low-grade endotoxemia-induced mastitis..
-
10) Manganese-based nanozymes as broad-spectrum antioxidants against cisplatin-induced skeletal muscle atrophy.
-
11) Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice.
-
12) PIEZO1 mediates periostin+ myofibroblast activation and pulmonary fibrosis in mice.
-
13) Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs.
-
14) Nanosensitizer for enhanced radiotherapy via tumor microenvironment reshaping and ROS amplification.
-
15) Excessive collagen type VII mediates pleural fibrosis via increasing extracellular matrix stiffness.